Washington University in St. Louis announced plans to acquire the University of Health Sciences and Pharmacy’s St. Louis College of Pharmacy, folding the historic pharmacy program into WashU as its 10th school and phasing out UHSP programs not transferred. The transaction is subject to regulatory approvals and a transition period that could take 12–18 months. UHSP enrollment has declined sharply over the past decade and the institution carries notable long‑term debt; WashU framed the move as expanding interdisciplinary health offerings and strengthening population‑health ties. Financial terms were not disclosed, and UHSP said some arts and sciences degrees will be phased out after the 2026‑27 year. The deal highlights a pattern of regional consolidation as specialized colleges with enrollment and balance‑sheet pressures seek alignments with larger research universities. Provosts and finance officers should watch for regulatory conditions, faculty transfer agreements, program teach‑out plans, and donor or research‑grant implications.